European Healthtech startup funding raised during H1 2026.
In H1 2026, 235 European Healthtech companies raised a combined €4.3B across 238 funding rounds, up 8.0% versus H1 2025. UK led by capital raised, and High-Tech Gründerfonds (HTGF) was the most active investor. Data as of 9 Jul 2026.
17 exits · €1.0B disclosed.
| Saga Diagnostics | Acquisition | Apr 2026 | €504M |
| Kaia Health | Acquisition | Jan 2026 | €239M |
| Gleamer | Acquisition | Mar 2026 | €230M |
| €86M |
| Ona Therapeutics | Series B | Jun 2026 | €74M |
| DentalMonitoring | Other | Feb 2026 | €71M |
| Neurent Medical | Series C | Feb 2026 | €63M |
| Vitestro | Series B | Mar 2026 | €60M |
| Uromems | Growth/Late | May 2026 | €52M |
| Exciva | Series B | Jan 2026 | €51M |
| FineHeart | Grant | Jan 2026 | €48M |
| Storm Therapeutics | Series C | Apr 2026 | €48M |
| NVision Imaging | Series B | May 2026 | €47M |
| IMU Biosciences | Other | Jun 2026 | €45M |
| Biorce | Series A | Feb 2026 | €44M |
